No Data
No Data
Beam Therapeutics Picks Ironwood Pharmaceuticals Finance and Operations Chief as CFO
Express News | Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer
Lake Street Sticks to Its Buy Rating for Assertio Therapeutics (ASRT)
Assertio Holdings Analyst Ratings
H.C. Wainwright Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $4
Assertio Therapeutics: Strong Buy Rating Backed by Robust Margins and Strategic Revenue Growth
White_Shadow : yup
White_Shadow : seems like every executive just loaded up Boat load of shares....this is an excellent strong positive